Cite
Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)
MLA
Bartomeu Massuti, et al. Oral Vinorelbine versus Etoposide with Cisplatin and Chemo-Radiation as Treatment in Patients with Stage III Non-Small Cell Lung Cancer: A Randomized Phase II (RENO Study). Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....411fe6d05d5f2a5eb759bf673c22162a&authtype=sso&custid=ns315887.
APA
Bartomeu Massuti, Ramon De Las Penas, Mariano Provencio, José Miguel Jurado, María Francisca Vázquez, Raquel Marsé, Dolores Isla, Natividad Martínez-Banaclocha, Pilar Diz, José Gómez-Codina, Pilar Mut, María Ángeles Sala, A. Insa, Vanesa Gutiérrez, Nuria Viñolas, Melchor Álvarez de Mon Soto, Rosa Alvarez, Ana Laura Ortega, I. Maestu, … Teresa Moran. (2019). Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).
Chicago
Bartomeu Massuti, Ramon De Las Penas, Mariano Provencio, José Miguel Jurado, María Francisca Vázquez, Raquel Marsé, Dolores Isla, et al. 2019. “Oral Vinorelbine versus Etoposide with Cisplatin and Chemo-Radiation as Treatment in Patients with Stage III Non-Small Cell Lung Cancer: A Randomized Phase II (RENO Study),” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....411fe6d05d5f2a5eb759bf673c22162a&authtype=sso&custid=ns315887.